Concepedia
Statistics
Publications
14
Citations
1.6K
H-Index
13
Active since
2001
Affiliations
GlaxoSmithKline (United States)(Current)
Research Triangle Park Foundation
University of North Carolina at Chapel Hill
GlaxoSmithKline (United Kingdom)
Age UK
Jennifer L. Aponte is an author at GlaxoSmithKline (United States) specializing in life sciences, genetics, and medical genetics.
Publications per year
2001–2020
An Abundance of Rare Functional Variants in 202 Drug Target Genes Sequenced in 14,002 People
Matthew R. Nelson, Daniel Wegmann, Margaret G. Ehm et al. · Science · 2012 · 702 citations · Full text
Life Sciences, Genetics, Molecular Genetics +14
Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility
Jennifer Wessel, Audrey Y. Chu, Sara M. Willems et al. · Nature Communications · 2015 · 201 citations · Full text
Life Sciences, Genetics, Molecular Genetics +16
The <i>SERPINE2</i> Gene is Associated with Chronic Obstructive Pulmonary Disease in Two Large Populations
Guohua Zhu, Liling Warren, Jennifer L. Aponte et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 137 citations
A genomic approach to therapeutic target validation identifies a glucose-lowering <i>GLP1R</i> variant protective for coronary heart disease
Robert A. Scott, Daniel F. Freitag, Li Li et al. · Science Translational Medicine · 2016 · 119 citations · Full text
Medicine, Endocrinology, Pharmacology +17
High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients
Gbenga Kazeem, Charles Cox, Jennifer L. Aponte et al. · Pharmacogenetics and Genomics · 2009 · 109 citations
Life Sciences, Genetics, Pharmacology +13
1–5 of 14